Alterity Therapeutics Cash Flow Statement (2015-2025) | ATHE

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Jun2021 Dec2021 Jun2022 Dec2022 Dec2023 Jun2024 Dec2024 Dec2025
Operating Activities
Net Income (Quarter) -2.74M-2.78M-3.83M-3.85M
Depreciation and Depletion (Quarter) 0.01M0.02M-0.01M0.02M-0.01M165.030.01M0.02M0.01M0.02M0.00M0.01M0.01M0.01M0.00M
Cash from Discontinued Operations (Quarter) -0.47M
Gains from Investment Securities (Quarter) 0.04M
Change in Working Capital (Quarter) -1033.60M-111.66M43.69M-7865.46M
Cash from Operations (Quarter) -5.54M-0.47M-4.41M-0.90M-0.05M-5.18M-9.77M-1.77M-6.18M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.01M0.02M-0.01M0.02M-0.01M165.030.01M0.02M0.01M0.02M0.00M0.01M0.01M0.01M0.00M
Change in Working Capital
Change in Receivables (Quarter) -1.96M1.30M-2.21M1.31M-1.22M-884.501.75M-1.17M-2.02M0.90M
Change in Account Payables (Quarter) -5.13M-0.30M-0.28M-0.64M-3.25M0.01M-0.41M0.46M5.07M-0.43M
Change in Accured Expenses (Quarter) 0.02M-0.01M0.07M0.09M-824.180.03M0.03M-0.05M-0.00M
Other Working Capital Changes (Quarter) -0.03M-0.09M-0.10M-0.00M0.05M143.75-0.11M-0.26M-0.22M0.04M
Investing Activities
Capital Expenditures (Quarter) -0.02M-0.00M-0.00M-0.01M
Divestments (Quarter) -0.02M
Cash from Investing Activities (Quarter) -0.02M-0.00M-0.00M-0.01M
Financing Activities
Other financing activities (Quarter) -0.12M
Cash from Financing Activities (Quarter) -0.12M-0.03M0.10M0.17M
Additional items
Exchange Rate Effect (Quarter) -0.71M0.41M-0.47M0.00M0.16M-0.28M0.09M-0.17M
Change in Cash (Quarter) -0.60M-0.93M-5.08M-1.60M
Free Cash Flow (Quarter) -5.54M-0.45M-4.41M-0.90M-0.05M-5.18M-9.77M-1.76M-6.18M
Net Cash Flow (Quarter) -5.54M-0.60M-4.41M-0.93M-0.05M-5.08M-9.77M-1.60M-6.18M